{"id":155227,"date":"2021-02-15T03:13:40","date_gmt":"2021-02-15T08:13:40","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/bio-path-holdings-inc-announces-proposed-public-offering-of-common-stock\/"},"modified":"2024-08-18T11:43:38","modified_gmt":"2024-08-18T15:43:38","slug":"bio-path-holdings-inc-announces-proposed-public-offering-of-common-stock","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/bio-path-holdings-inc-announces-proposed-public-offering-of-common-stock.php","title":{"rendered":"Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock"},"content":{"rendered":"<p><![CDATA[HOUSTON, Feb.  13, 2021  (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.]]><\/p>\n<p>Continue reading here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/02\/13\/2175199\/0\/en\/Bio-Path-Holdings-Inc-Announces-Proposed-Public-Offering-of-Common-Stock.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock\">Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continue reading here: Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/bio-path-holdings-inc-announces-proposed-public-offering-of-common-stock.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-155227","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155227"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=155227"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155227\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=155227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=155227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=155227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}